Allied Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	789.08	978.33	618.49	679.75	757.39
Short-Term Investments	64.83	8.91	106.28	113.25	386.82
Cash & Short-Term Investments	853.91	987.24	724.77	793	1,144
Cash Growth	-13.51%	36.21%	-8.60%	-30.69%	19.27%
Accounts Receivable	137.95	131.24	109.85	118.54	105.08
Other Receivables	1.53	1.75	3.6	5.39	4.63
Receivables	139.48	132.99	113.46	123.92	109.71
Inventory	511.41	527.54	601.48	596.47	508.09
Other Current Assets	16.68	15.33	17.17	21.54	23.52
Total Current Assets	1,521	1,663	1,457	1,535	1,786
Property, Plant & Equipment	540.7	567.87	594	623.49	625.99
Long-Term Investments	-	-	0.05	0.73	2.59
Long-Term Deferred Tax Assets	21.57	16.67	17.37	12.55	15.44
Other Long-Term Assets	8.05	9.22	10.62	11.31	11.84
Total Assets	2,092	2,257	2,079	2,183	2,441
Accounts Payable	31.1	26.66	27.65	38.64	47.21
Accrued Expenses	49.8	47.94	35.5	43.78	30.61
Short-Term Debt	670	870	700	720	1,110
Current Portion of Long-Term Debt	18.31	18.31	18.31	18.31	125.99
Current Portion of Leases	5.05	5.36	5.1	5.49	5.79
Current Income Taxes Payable	15.12	10.88	16.85	27.46	1.64
Current Unearned Revenue	1.69	2.6	4.64	1.26	1.59
Other Current Liabilities	8.98	14.5	20.65	39.84	23.91
Total Current Liabilities	800.04	996.25	828.69	894.77	1,347
Long-Term Debt	34.46	52.76	71.07	89.38	-
Long-Term Leases	4.1	7.74	0.95	3.89	1.03
Pension & Post-Retirement Benefits	8.95	-	5.92	3.94	9.64
Long-Term Deferred Tax Liabilities	9.64	4.57	3.49	7.43	2.47
Total Liabilities	857.19	1,061	910.12	999.4	1,360
Common Stock	962.43	960.24	957.85	953.85	953.51
Additional Paid-In Capital	12.13	9.65	7.74	5.67	5.19
Retained Earnings	263.95	231.31	209.28	229.88	127.6
Comprehensive Income & Other	-3.9	-5.67	-6.08	-5.79	-4.79
Shareholders' Equity	1,235	1,196	1,169	1,184	1,082
Total Liabilities & Equity	2,092	2,257	2,079	2,183	2,441
Total Debt	731.91	954.17	795.43	837.07	1,243
Net Cash (Debt)	122	33.07	-70.66	-44.06	-98.6
Net Cash Growth	268.93%	-	-	-	-
Net Cash Per Share	1.27	0.34	-0.74	-0.46	-1.03
Filing Date Shares Outstanding	96.24	96.02	95.78	95.38	95.35
Total Common Shares Outstanding	96.24	96.02	95.78	95.38	95.35
Working Capital	721.44	666.85	628.19	640.17	438.79
Book Value Per Share	12.83	12.45	12.20	12.41	11.34
Tangible Book Value	1,235	1,196	1,169	1,184	1,082
Tangible Book Value Per Share	12.83	12.45	12.20	12.41	11.34
Land	210.22	210.22	210.22	210.22	210.22
Buildings	290.85	288.9	286.98	258.26	263.3
Machinery	981.77	965.22	950.97	915.59	858.72
Construction In Progress	14.98	6.07	6.96	42.43	56.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.